Published in FASEB J on November 01, 2000
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
p53 mutations in cancer. Nat Cell Biol (2013) 5.18
Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell (2014) 3.68
Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol (2010) 3.65
The rebel angel: mutant p53 as the driving oncogene in breast cancer. Carcinogenesis (2012) 1.67
An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations. J Clin Invest (2007) 1.64
Links between mutant p53 and genomic instability. J Cell Biochem (2012) 1.41
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis. Nat Struct Mol Biol (2009) 1.39
Mutant p53 mediates survival of breast cancer cells. Br J Cancer (2009) 1.33
Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells. Nat Commun (2013) 0.95
Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells. Br J Pharmacol (2005) 0.90
Allele specific gain-of-function activity of p53 mutants in lung cancer cells. Biochem Biophys Res Commun (2012) 0.89
Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression. Oncotarget (2015) 0.82
Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin β4 and Akt signals. Sci Rep (2015) 0.79
Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers. Dis Model Mech (2016) 0.77
The effect of regular exercise on development of sarcoma tumor and oxidative damage in mice liver. J Sports Sci Med (2011) 0.77
The gain of function of p53 mutant p53S in promoting tumorigenesis by cross-talking with H-RasV12. Int J Biol Sci (2012) 0.76
Oncogenic Intra-p53 Family Member Interactions in Human Cancers. Front Oncol (2016) 0.75
Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells. Mol Oncol (2017) 0.75
Comparison of effects of p53 null and gain-of-function mutations on salivary tumors in MMTV-Hras transgenic mice. PLoS One (2015) 0.75
Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16
An interactive graphics-based model of the lower extremity to study orthopaedic surgical procedures. IEEE Trans Biomed Eng (1990) 5.65
Metastatic prostate cancer in a transgenic mouse. Cancer Res (1996) 4.02
Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression. Cell (1979) 3.78
Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci U S A (1999) 2.81
Application of high-tech three-dimensional imaging and computer-generated models in complex facial reconstructions with vascularized bone grafts. Plast Reconstr Surg (1993) 2.77
Preparation and preliminary characterization of purified ovalbumin messenger RNA from the hen oviduct. Biochemistry (1975) 2.42
Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development (1996) 2.35
Physical and chemical characterization of purified ovalbumin messenger RNA. J Biol Chem (1975) 2.28
C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev (1998) 2.27
The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol (1994) 2.22
C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol (2000) 2.11
Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol (2001) 2.05
Overlapping sites for constitutive and induced DNA binding factors involved in interferon-stimulated transcription. EMBO J (1989) 1.87
Comparison of the whey acidic protein genes of the rat and mouse. Nucleic Acids Res (1984) 1.81
Complex hormonal regulation of rat casein gene expression. J Biol Chem (1982) 1.80
Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology (1996) 1.74
Use of a specific probe for ovalbumin messenger RNA to quantitate estrogen-induced gene transcripts. Biochemistry (1975) 1.69
Regulation of casein messenger RNA during the development of the rat mammary gland. Biochemistry (1975) 1.66
Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol Endocrinol (1997) 1.50
Isolation and characterization of functional mammary gland stem cells. Cell Prolif (2003) 1.49
Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J Natl Cancer Inst (1997) 1.47
The rat casein multigene family. I. Fine structure of the gamma-casein gene. J Biol Chem (1983) 1.45
Acute eosinophilic pneumonia associated with shock. Crit Care Med (1999) 1.45
Rat beta casein cDNA: sequence analysis and evolutionary comparisons. Nucleic Acids Res (1982) 1.44
Nuclear factor I and mammary gland factor (STAT5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice. Mol Cell Biol (1995) 1.37
Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development. Mol Endocrinol (1994) 1.36
Comparative sequence analysis of the mRNAs coding for mouse and rat whey protein. Nucleic Acids Res (1982) 1.35
Adenovirus-Cre-mediated recombination in mammary epithelial early progenitor cells. J Cell Sci (2001) 1.34
Localization of the casein gene family to a single mouse chromosome. J Cell Biol (1982) 1.33
Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression. Mol Endocrinol (1995) 1.32
The rat casein multigene family. Fine structure and evolution of the beta-casein gene. J Biol Chem (1985) 1.30
Evaluation of a fiber optic glove for semi-automated goniometric measurements. J Rehabil Res Dev (1990) 1.29
Evolution of the casein multigene family: conserved sequences in the 5' flanking and exon regions. Nucleic Acids Res (1986) 1.28
Prolactin induction of casein mRNA in organ culture. A model system for studying peptide hormone regulation of gene expression. J Biol Chem (1978) 1.27
neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol Cell Biol (1997) 1.27
Measurement of mRNA concentration and mRNA half-life as a function of hormonal treatment. Methods Enzymol (1985) 1.25
A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res (2001) 1.21
Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol (2001) 1.21
Both cell substratum regulation and hormonal regulation of milk protein gene expression are exerted primarily at the posttranscriptional level. Mol Cell Biol (1988) 1.20
Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol Endocrinol (1999) 1.18
Construction and preliminary characterization of the rat casein and alpha-lactalbumin cDNA clones. J Biol Chem (1981) 1.18
Tissue-specific expression of the rat beta-casein gene in transgenic mice. Nucleic Acids Res (1988) 1.16
Progesterone-mediated inhibition of casein mRNA and polysomal casein synthesis in the rat mammary gland during pregnancy. Biochemistry (1978) 1.16
Localization and quantification of Wnt-2 gene expression in mouse mammary development. Dev Biol (1993) 1.16
Isolation and characterization of purified rat casein messenger ribonucleic acids. Biochemistry (1976) 1.13
Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor. Mol Endocrinol (2001) 1.13
Regulation of mammary gland factor/Stat5a during mammary gland development. Mol Endocrinol (1995) 1.11
Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A. J Biol Chem (1999) 1.11
Multihormonal regulation of casein gene expression at the transcriptional and posttransciptional levels in the mammary gland. Recent Prog Horm Res (1980) 1.10
Sequence of rat alpha- and gamma-casein mRNAs: evolutionary comparison of the calcium-dependent rat casein multigene family. Nucleic Acids Res (1982) 1.10
Distal regulatory elements required for rat whey acidic protein gene expression in transgenic mice. J Biol Chem (1994) 1.09
Quantitation of casein messenger ribonucleic acid sequences using a specific complementary DNA hybridization probe. Biochemistry (1976) 1.09
A transgenic mouse model for mammary carcinogenesis. Oncogene (1998) 1.08
Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice. Oncogene (1999) 1.07
Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma. Cancer Gene Ther (2011) 1.07
Differential regulation of rat beta-casein-chloramphenicol acetyltransferase fusion gene expression in transgenic mice. Mol Cell Biol (1989) 1.06
Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland. Endocrinology (2003) 1.05
P190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer. Cell Growth Differ (2000) 1.05
Tissue-specific, high level expression of the rat whey acidic protein gene in transgenic mice. Nucleic Acids Res (1990) 1.04
Detection of mouse mammary tumor virus RNA in BALB/c tumor cell lines of nonviral etiologies. J Virol (1978) 1.04
Preferential overexpression of a 172Arg-->Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development. Cell Growth Differ (1994) 1.03
Glucocorticoid regulation of rat whey acidic protein gene expression involves hormone-induced alterations of chromatin structure in the distal promoter region. Mol Endocrinol (1994) 1.02
Backscattersonde: a new instrument for atmospheric aerosol research. Appl Opt (1991) 1.02
Steroid hormone regulation of specific messenger RNA and protein synthesis in eucaryotic cells. J Cell Physiol (1975) 0.99
Use of PRKO mice to study the role of progesterone in mammary gland development. J Mammary Gland Biol Neoplasia (1997) 0.97
Differential interactions of specific nuclear factor I isoforms with the glucocorticoid receptor and STAT5 in the cooperative regulation of WAP gene transcription. Mol Cell Biol (2001) 0.96
High-level expression of the rat whey acidic protein gene is mediated by elements in the promoter and 3' untranslated region. Mol Cell Biol (1992) 0.96
Multihormonal regulation of milk protein gene expression. Ann N Y Acad Sci (1986) 0.95
Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function. Cell Growth Differ (1997) 0.94
Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells. Cell Growth Differ (2001) 0.94
Concepts of peripheral nerve repair. Ann Plast Surg (1981) 0.94
A clonal derivative of mammary epithelial cell line COMMA-D retains stem cell characteristics of unique morphological and functional heterogeneity. Exp Cell Res (1988) 0.94
Restriction enzyme mapping and heteroduplex analysis of the rat milk protein cDNA clones. J Biol Chem (1981) 0.92
Differential expression of poly(A)-adjacent sequences of mammary tumor virus RNA in murine mammary cells. Proc Natl Acad Sci U S A (1978) 0.92
Gene expression in normal and neoplastic mammary tissue. Biochemistry (1980) 0.92
Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis. Oncogene (2000) 0.91
Inhibition of glucose uptake in lymphosarcoma P1798 by cortisol and its relationship to the biosynthesis of deoxyribonucleic acid. J Biol Chem (1970) 0.91
Mutant p53 and genomic instability in a transgenic mouse model of breast cancer. Oncogene (2000) 0.91
Monitoring in microvascular surgery. Ann Plast Surg (1991) 0.89
Mammary tumour virus and casein gene transcription during mouse mammary development. Nature (1978) 0.88
Infarction of the upper limbs associated with oligohydramnios and intrauterine compression. J Hand Surg Am (1988) 0.88
Single breath counting in the assessment of pulmonary function. Ann Emerg Med (1994) 0.87
Comparative biochemical studies of adriamycin and daunomycin in leukemic cells. Cancer Res (1972) 0.86
Difference between mammary epithelial cells from mature virgin and primiparous mice. Cancer Res (1978) 0.86
Atypical presentation of pulmonary embolism. Ann Emerg Med (1990) 0.86
Effect of estrogen on gene expression in the chick oviduct. I. Deoxyribonucleic acid--deoxyribonucleic acid renaturation studies. Biochemistry (1973) 0.86
The nerve gap dilemma: a comparison of nerves repaired end to end under tension with nerve grafts in a primate model. J Hand Surg Am (1993) 0.86
Regulatory sequences involved in the hormonal control of casein gene expression. Ann N Y Acad Sci (1986) 0.85
A transfected alpha-casein minigene bypasses posttranscriptional control by hormones, but retains cell-substratum regulation in mammary epithelial cells. Mol Endocrinol (1988) 0.85
Delay of dimethylbenz[a]anthracene-induced mammary tumorigenesis in transgenic mice by apoptosis induced by an unusual mutant p53 protein. Mol Carcinog (1995) 0.85
Inhibitory effect of cortisol in vitro on 2-deoxyglucose uptake and RNA and protein metabolism in lymphosarcoma P1798. Cancer Res (1972) 0.85
Hormone-dependent beta-casein mRNA stabilization requires ongoing protein synthesis. Mol Endocrinol (1989) 0.84
Effect of estrogen on gene expression in the chick oviduct. II. Transcription of chick tritiated unique deoxyribonucleic acid as measured by hybridization in ribonucleic acid excess. Biochemistry (1973) 0.84
Transcriptional analysis of the mouse beta-casein gene. Mol Endocrinol (1990) 0.84
Production of active bovine tracheal antimicrobial peptide in milk of transgenic mice. Proc Natl Acad Sci U S A (1996) 0.84
Nontraumatic fat embolization. A rare cause of new pulmonary infiltrates in an immunocompromised patient. Am Rev Respir Dis (1986) 0.83
Regeneration microelectrode array for peripheral nerve recording and stimulation. IEEE Trans Biomed Eng (1992) 0.83
Position-independent expression of whey acidic protein transgenes. J Biol Chem (1995) 0.82